Sarepta Therapeutics, Inc. SRPT Reduction In The Carrying Amounts Of The Right Of Use Assets
Reduction In The Carrying Amounts Of The Right Of Use Assets at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:ReductionInTheCarryingAmountsOfTheRightOfUseAssets.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s reduction in the carrying amounts of the right of use assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s reduction in the carrying amounts of the right of use assets?
- Sarepta Therapeutics, Inc. (SRPT) reported reduction in the carrying amounts of the right of use assets of $3.11M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s reduction in the carrying amounts of the right of use assets changed year-over-year?
- Sarepta Therapeutics, Inc.'s reduction in the carrying amounts of the right of use assets decreased by 20.9% year-over-year, from $3.93M to $3.11M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s reduction in the carrying amounts of the right of use assets?
- Over 4 years (2021 to 2025), Sarepta Therapeutics, Inc.'s reduction in the carrying amounts of the right of use assets has grown at a 5.4% compound annual growth rate (CAGR), from $11.33M to $13.95M.
- What does reduction in the carrying amounts of the right of use assets mean?
- Represents the non-cash amortization or impairment of right-of-use assets associated with operating leases. This adjustment aligns the income statement expense with the underlying lease liability reduction over the term of the contract.